COORDINATED RESEARCH ACTIVITIES...COORDINATED RESEARCH ACTIVITIES - NAHU BUDGET - 2014 Programme/...

29
COORDINATED RESEARCH ACTIVITIES Alfredo Polo International Atomic Energy Agency Vienna, Austria

Transcript of COORDINATED RESEARCH ACTIVITIES...COORDINATED RESEARCH ACTIVITIES - NAHU BUDGET - 2014 Programme/...

COORDINATED RESEARCH ACTIVITIES

Alfredo PoloInternational Atomic Energy Agency

Vienna, Austria

COORDINATED RESEARCH ACTIVITIES REPRESENT A SIGNIFICANT COMPONENT OF THE IAEA OPERATIONS

Radiotracer technologies

Prevention of cardiovascular disease and diabetes

Seafood Safety

Nuclear forensics

cour

tesy

of A

NST

O

Radioactive waste

Managing irrigation water

Radiation processing

Water security

Combating animal diseases

Sterile insect technique

Cancer treatment

Environmental monitoring

Seawater desalination

How to participate, as a research institution, in

Search for relevant CRPs that are open for List of IAEA Coordinated Research Activities by Major Programme, Programme and Project that are Open for Submission of Proposals;

Submit a Proposal for Research Contract or Agreement directly to the IAEA’s Research Contracts Administration Section, using the form template on the IAEA web site (preferably via

cra.iaea.org

The IAEA's Coordinated Research ActivitiesUniting the World through Research

The IAEA brings together research institutions

across the globe to collaborate in nuclear science

projects ranging from isotopes and radiation

applications in agriculture, human health, industry,

hydrology and terrestrial and marine environment to

nuclear energy and economic studies and nuclear

safety and security.

IAEA coordinated research activities (CRAs)

encourage both the acquisition and the

dissemination of new knowledge and technology

generated through the use of nuclear technologies

and isotopic techniques, as well as the adaptation

of these technologies in IAEA Member States.

Results of CRAs are disseminated to Member

States and the international scientific community

through publications and via IAEA technical

cooperation projects, under which CRA findings

are often applied practically.

The CRAs are implemented primarily via

coordinated research projects (CRPs) and their

related Research Coordination Meetings (RCMs).

Each CRP typically brings together 10–15 research

institutions from a range of countries at different

stages of socioeconomic development, which work

together. Research is conducted in the participating

institutions, with the IAEA coordinating the work

and organizing periodic RCMs, with CRPs designed

to contribute to building professional relationships

and networks which thrive beyond the lifetime of

the CRP.

How to participate, as a research institution, in

coordinated research activities:

Go to cra.iaea.org

9 Search for relevant CRPs that are open for

submission of proposals using:

• List of IAEA Coordinated Research Activities

by Major Programme, Programme and Project

that are Open for Submission of Proposals;

• CRP search.

9 Submit a Proposal for Research Contract or

Agreement directly to the IAEA’s Research

Contracts Administration Section, using the form

template on the IAEA web site (preferably via

email).

¾

¾CRA at a glance

¾ 120 active CRPs

¾ 1600 research institutions involved through research, technical and doctoral contracts or research agreements

¾ 70 RCMs organized per year

¾ €7 million annual budget

The International Atomic Energy Agency (IAEA) is authorized under its Statute to encourage and assist research on atomic energy for peaceful uses throughout the world as well as on its development and practical applications. The IAEA’s programme and budget for 2015 accordingly provide for the placing of research, technical and doctoral contracts and research agreements with universities, colleges, research centres, and laboratories, and other institutions in Member States on subjects directly related to the IAEA’s work.

•  CRPs  are  developed  to  solve  well-­‐defined  

research  topics  in  which  an  appropriate  

number  of  institutes  (10-­‐15)  are  invited  to  

collaborate  

•  CRPs  have  proven  to  be  an  effective  means  

of  bringing  together  researchers  from  both  

developing  and  industrialised  countries  to  

solve  a  problem  of  common  interest

COORDINATED  RESEARCH  ACTIVITIESCOORDINATED  RESEARCH  PROJECTS  (CRPs)

Participate  in  multinational  research  

Provide  answer  to  a  relevant  scientific  question  

Improve  routine  clinical  practice

75% 25%

NAHU Other

ACTIVE CRPs AT THE END OF 2014

125 Active CRPs 73 RCMs

TOTAL

31 Active CRPs 11 RCMs

NAHU

DISTRIBUTION OF CRPs

75% 25%

NAHU Other

ACTIVE CRPs AT THE END OF 2014

125 Active CRPs 73 RCMs

TOTAL

31 Active CRPs 11 RCMs

NAHU

NAHRES 8

NMDI 7

ARBR 11

DMRP 5

DISTRIBUTION OF CRPs IN NAHU

0

5

10

15

20

25

30

35

40

2000 2002 2004 2006 2008 2010 2012 2014

TEMPORAL EVOLUTION OF CRPsTOTAL NUMBER OF CRPs (NAHU)

Source: IAEA (anual reports) http://cra.iaea.org/cra/cra-resources/annual-reports.html

0

10

20

30

40

2000 2002 2004 2006 2008 2010 2012 2014

NAHRES NMDI ARBR DMRP

TEMPORAL EVOLUTION OF CRPsTOTAL NUMBER OF CRPs (NAHU)

Source: IAEA (anual reports) http://cra.iaea.org/cra/cra-resources/annual-reports.html

75% 25%

NAHU Other

ACTIVE CRAs AT THE END OF 2014

EUR 6.778.111

TOTAL

EUR 1.721.293

NAHU

DISTRIBUTION OF BUDGET

0 M €

1 M €

2 M €

3 M €

4 M €

5 M €

6 M €

7 M €

8 M €

2000 2002 2004 2006 2008 2010 2012 2014

TEMPORAL EVOLUTION OF BUDGETPERIOD 2000-2014

Source: IAEA (anual reports) http://cra.iaea.org/cra/cra-resources/annual-reports.html

0 M €

1 M €

2 M €

3 M €

4 M €

5 M €

6 M €

7 M €

8 M €

2000 2002 2004 2006 2008 2010 2012 2014

Total CRA budget NAHU budget

TEMPORAL EVOLUTION OF BUDGETPERIOD 2000-2014

Source: IAEA (anual reports) http://cra.iaea.org/cra/cra-resources/annual-reports.html

TEMPORAL EVOLUTION OF BUDGETPERIOD 2000-2014

Source: IAEA (anual reports) http://cra.iaea.org/cra/cra-resources/annual-reports.html

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Total budget 7,13 6,44 6,45 7,00 7,00 7,39 5,75 6,60 6,61 6,67 7,10 6,71 7,16 7,55 6,77

NAHU budget 1,57 1,55 1,39 1,71 1,49 1,81 1,40 1,73 1,90 2,06 2,03 1,46 1,58 1,84 1,72

In million €

COORDINATED RESEARCH ACTIVITIES - NAHU BUDGET - 2014

Programme/Project

Research contracts Technical contracts Doctoral contractsCRP

purchases Total €RCM

Overall total €No. Amount € No. Amount € No. Amount € No. Amount €

2000004 8 40000 40000 8 40008

2000010 18 185450 5 46500 14 155000 386950 49 70087 457037

2000015 58 359000 6 67500 89947 516447 29 53617 570064

2000024 46 238356 5 48000 286356 41 70974 357330

2000029 11 47600 2 10000 57600 57600

2000042 31 139189 139189 67 100065 239254

Sub-total 172 1009595 16 162000 16 165000 89947 1426542 186 294751 1721293

NAHU BUDGET - 2014

COORDINATED RESEARCH ACTIVITIES

17,12%

5,23%

9,59%

9,41%

58,65%

Research contracts Technical contracts Doctoral contracts CRP purchases RCM

NAHU BUDGET - 2014

COORDINATED RESEARCH ACTIVITIES

HOW CLINICAL RESEARCH IS CONDUCTED AT IAEA

DIFFERENT TYPES OF CRA SUPPORTED BY IAEA

WHY IS CLINICAL RESEARCH IMPORTANT FOR IAEA?

Clinical research funding is aligned with the mandate to the IAEA to encourage and assist research on atomic energy for peaceful uses

throughout the world as well as on its development and

practical applications.

Funding research to improve health globally delivers on the

IAEA commitment to international development

while also exploring research questions of relevance that would be difficult to address

otherwise. CRA is instrumental to build capacity in

methodological research in Member States

Funding clinical research activities reinforce the

leadership of IAEA in key areas of human health as cancer

control, nutrition and cardiovascular diseases.

Disseminating these activities will increase awareness and

increase access to this programme

Clinical Research at IAEA contributes to tackle the implementation of the

Sustainable Development Goals making IAEA a

trustworthy player in the Public Health community

Non-Communicable-Diseases have become a priority in

Global Health, but there is a significant gap in the

international agenda. IAEA has built a substantial Global

Health portfolio contributing with 1.7M€ per year to clinical research. In this way IAEA can

become a key player in the WHO NCD Action Plan

NAHU DIRECTOR

SH-NMDISH-ARBRSH-DMRPSH-NAHRES

HOW NAHU CONDUCTS CLINICAL RESEARCH

TO TO TO TO TO TO TO TO TO TO TO TO TO TO TO TO

CRP

DIRECTOR’S OFFICE

• Selection  of  topic  to  be  included  in  P&B  

• Formulation  and  Submission  of  Detailed  Proposals  for  New  CRPs  

• Announcement  of  Approved  New  CRPs  

• Submission  of  Research,  Technical  and  Doctoral  Contract  and  Agreement  Proposals  

• Evaluation  of  Research  Proposals  and  Selection  of  CRP  Participants  

• Research,  Technical  and  Doctoral  Contracts  and  Research  Agreements  

• Preparation  of  Contracts  and  Agreements  

• Funding  of  the  Coordinated  Research  Activities  

• Research  Coordination  Meetings  (RCMs)  1-­‐2-­‐3  (+  reporting)  

• Review  of  CRPs  Evaluation  of  Completed  CRPs  

• Publication  of  CRP  Results

COORDINATED  RESEARCH  PROJECTSTHE  BASIC  PROCESS  OF  A  CRP

COORDINATED  RESEARCH  PROJECTSGEOGRAPHICAL  DISTRIBUTION  -­‐  NAHU  PROJECTS  -­‐  ACTIVE

COORDINATED  RESEARCH  PROJECTSGEOGRAPHICAL  DISTRIBUTION  -­‐  ARBR  PROJECTS  -­‐  ACTIVE

SOME  PUBLISHED  RESULTS• Jeremic B, Fidarova E, Sharma V et al. The International Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell

lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting. Radiother Oncol. 2015;116:21-26.!• Hassan Metwally MA, Ali R, Kuddu M et al. Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck

squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole. Acta Oncol. 20151-4.!• Hassan Metwally MA, Ali R, Kuddu M et al. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated

radiotherapy in head and neck squamous cell carcinoma. Radiother Oncol. 2015;116:15-20.!• Hoskin P, Rojas A, Fidarova E et al. IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. Radiother Oncol.

2015;116:10-14.!• Rosenblatt E, Abdel-Wahab M, El-Gantiry M et al. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the

International Atomic Energy Agency. Radiat Oncol. 2014;9:67.!• Overgaard J, Mohanti BK, Begum N et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a

randomised, multicentre trial. Lancet Oncol. 2010!• Rosenblatt E, Jones G, Sur RK et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a

prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol. 2010;97:488-494.!• Dobrowsky W, Huigol NG, Jayatilake RS et al. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre

randomised trial. Radiother Oncol. 2007;82:24-29.!• Vasanthan A, Mitsumori M, Park JH et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial

of the international atomic energy agency. Int J Radiat Oncol Biol Phys. 2005;61:145-153.!• Grau C, Prakash Agarwal J, Jabeen K et al. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA

multicentre randomised trial. Radiother Oncol. 2003;67:17-26.!• Salazar OM, Sandhu T, da Motta NW et al. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a

randomized Phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys. 2001;50:765-775.

Vasanthan  A,  Mitsumori  M,  Park  JH  et  al.  Regional  hyperthermia  combined  with  radiotherapy  for  uterine  cervical  cancers:  a  mulB-­‐insBtuBonal  prospecBve  randomized  trial  of  the  internaBonal  atomic  energy  agency.  Int  J  Radiat  Oncol  Biol  Phys.  2005;61:145-­‐153.  

Salazar  OM,  Sandhu  T,  da  MoRa  NW  et  al.  FracBonated  half-­‐body  irradiaBon  (HBI)  for  the  rapid  palliaBon  of  widespread,  symptomaBc,  metastaBc  bone  disease:  a  randomized  Phase  III  trial  of  the  InternaBonal  Atomic  Energy  Agency  (IAEA).  Int  J  Radiat  Oncol  Biol  Phys.  2001;50:765-­‐775.

Dobrowsky  W,  Huigol  NG,  JayaBlake  RS  et  al.  AK-­‐2123  (Sanazol)  as  a  radiaBon  sensiBzer  in  the  treatment  of  stage  III  cervical  cancer:  results  of  an  IAEA  mulBcentre  randomised  trial.  Radiother  Oncol.  2007;82:24-­‐29.

CONCLUSION

TECHNICAL  COOPERATION

HUMAN  HEALTH  DIVISION

The  Coordinated  Research  Activities  are  complementary  to  the  Agency’s  Technical  Cooperation  Projects  (TCPs),  with  the  knowledge  gained  via  coordinated  research  used  to  enhance  the  quality  of  Technical  Cooperation  Projects.

CONCLUSIONS

•  Coordinated  research  activities  permit  the  acquisition  and  dissemination  of    new  

knowledge  and  technologies,  as  well  as  the  adaptation  to  the  needs  of  the  MS  

•  Knowledge  generated  by  CRAs  can  improve  the  quality  of  TC  projects  

•  Coordinated  research  activities  contribute  to  capacity  building  in  clinical  research  

•  Evidence  generated  from  CRPs  can  support  adapted  recommendation